RCA
LH icon

Resonant Capital Advisors’s Labcorp LH Stock Holding History

Resonant Capital Advisors’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09M Buy
4,084
+311
+8% +$84.2K 0.06% 169
2025
Q4 		$947K Buy
3,773
+138
+4% +$36.7K 0.05% 168
2025
Q3 		$1.04M Buy
3,635
+8
+0.2% +$2.14K 0.06% 164
2025
Q2 		$952K Buy
3,627
+134
+4% +$32.6K 0.06% 164
2025
Q1 		$813K Buy
3,493
+51
+1% +$12.4K 0.06% 162
2024
Q4 		$789K Buy
3,442
+34
+1% +$7.8K 0.06% 167
2024
Q3 		$762K Buy
3,408
+36
+1% +$7.91K 0.06% 173
2024
Q2 		$686K Buy
3,372
+320
+10% +$65.1K 0.06% 172
2024
Q1 		$667K Buy
3,052
+33
+1% +$7.27K 0.06% 173
2023
Q4 		$686K Sell
3,019
-190
-6% -$39.9K 0.07% 164
2023
Q3 		$645K Sell
3,209
-326
-9% -$68.8K 0.07% 153
2023
Q2 		$733K Buy
3,535
+74
+2% +$14.4K 0.08% 143
2023
Q1 		$682K Buy
3,461
+89
+3% +$18.3K 0.08% 144
2022
Q4 		$682K Sell
3,372
-12
-0.4% -$2.35K 0.09% 140
2022
Q3 		$595K Buy
3,384
+56
+2% +$11.5K 0.09% 134
2022
Q2 		$670K Buy
3,328
+110
+3% +$23.4K 0.1% 126
2022
Q1 		$728K Buy
3,218
+179
+6% +$42.1K 0.11% 116
2021
Q4 		$820K Buy
3,039
+71
+2% +$17.6K 0.12% 97
2021
Q3 		$718K Buy
2,968
+561
+23% +$141K 0.12% 99
2021
Q2 		$570K Buy
2,407
+14
+0.6% +$3.19K 0.11% 102
2021
Q1 		$524K Buy
2,393
+9
+0.4% +$1.81K 0.11% 99
2020
Q4 		$417K Buy
2,384
+110
+5% +$19K 0.1% 117
2020
Q3 		$368K Sell
2,274
-481
-17% -$76.2K 0.1% 114
2020
Q2 		$393K Sell
2,755
-1,854
-40% -$257K 0.11% 122
2020
Q1 		$501K Buy
4,609
+337
+8% +$48.6K 0.18% 126
2019
Q4 		$621K Buy
+4,272
New +$617K 0.2% 127

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Resonant Capital Advisors's LH Position: Q1 2026 in Review

Resonant Capital Advisors increased its Labcorp (LH) stake by 8.2% in Q1 2026, buying an estimated $84.2K and bringing the position to 4,084 shares worth $1.09M. The position accounts for 0.06% of the portfolio, ranked #169.

Resonant Capital Advisors first reported a position in LH in Q4 2019 and has held it in 26 quarters since. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Resonant Capital Advisors held 4,084 shares of Labcorp worth $1.09M as of Q1 2026.
  • Resonant Capital Advisors bought 311 Labcorp shares in Q1 2026, an estimated $84.2K.
  • Labcorp made up 0.06% of Resonant Capital Advisors's portfolio in Q1 2026, its #169 holding.
  • Resonant Capital Advisors first reported a position in Labcorp in Q4 2019 and has held it in 26 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Resonant Capital Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.